BACKGROUND Results of the Fractional flow reserve versus Angiography for Multivessel Evaluation 2 (FAME 2) trial were recently presented at the European Society of Cardiology (ESC) meeting in Munich and published concurrently in the New England Journal of Medicine. Interpretation of the results and clinical significance of the study continue to be topics of considerable controversy. FAME 2 is a...
